RCKT CIK: 1281895

Rocket Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.36
FY23:
0.38
FY24:
0.38
FY25:
0.19
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.19
FY23:
0.19
FY24:
0.15
FY25:
0.14
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.50
FY22:
0.55
FY23:
0.57
FY24:
0.53
FY25:
0.33

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.04
FY23:
0.05
FY24:
0.04
FY25:
0.03
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.03
FY24:
0.02
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.49
FY23:
0.49
FY24:
0.46
FY25:
0.28
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.50
FY22:
0.55
FY23:
0.57
FY24:
0.53
FY25:
0.33

All amounts in billions USD Data source:SEC EDGAR